These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Challenges in the Development of Therapy for Dry Age-Related Macular Degeneration. Wei CX, Sun A, Yu Y, Liu Q, Tan YQ, Tachibana I, Zeng H, Wei JY. Adv Exp Med Biol; 2016; 854():103-9. PubMed ID: 26427400 [Abstract] [Full Text] [Related]
5. Disease progression and the need for neuroprotection in glaucoma management. Varma R, Peeples P, Walt JG, Bramley TJ. Am J Manag Care; 2008 Feb; 14(1 Suppl):S15-9. PubMed ID: 18284311 [Abstract] [Full Text] [Related]
10. Status and perspectives of neuroprotective therapies in glaucoma: the European Glaucoma Society White Paper. Tamm ER, Schmetterer L, Grehn F. Cell Tissue Res; 2013 Aug; 353(2):347-54. PubMed ID: 23712457 [Abstract] [Full Text] [Related]
20. Glaucoma as a neuropathy amenable to neuroprotection and immune manipulation. Schwartz M, London A. Prog Brain Res; 2008 Aug; 173():375-84. PubMed ID: 18929122 [Abstract] [Full Text] [Related] Page: [Next] [New Search]